259 related articles for article (PubMed ID: 30769255)
21. Neuromyelitis optica spectrum disorders with antibodies to myelin oligodendrocyte glycoprotein or aquaporin-4: Clinical and paraclinical characteristics in Algerian patients.
Bouzar M; Daoudi S; Hattab S; Bouzar AA; Deiva K; Wildemann B; Reindl M; Jarius S
J Neurol Sci; 2017 Oct; 381():240-244. PubMed ID: 28991690
[TBL] [Abstract][Full Text] [Related]
22. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin.
Jarius S; Ruprecht K; Kleiter I; Borisow N; Asgari N; Pitarokoili K; Pache F; Stich O; Beume LA; Hümmert MW; Trebst C; Ringelstein M; Aktas O; Winkelmann A; Buttmann M; Schwarz A; Zimmermann H; Brandt AU; Franciotta D; Capobianco M; Kuchling J; Haas J; Korporal-Kuhnke M; Lillevang ST; Fechner K; Schanda K; Paul F; Wildemann B; Reindl M;
J Neuroinflammation; 2016 Sep; 13(1):279. PubMed ID: 27788675
[TBL] [Abstract][Full Text] [Related]
23. Neuromyelitis optica spectrum disorder coexisting with ankylosing spondylitis: A case report.
Lin J; Zhang J; Liu X; Gong X; Li A; Zhou D; Hong Z
Mult Scler Relat Disord; 2020 May; 40():101979. PubMed ID: 32036261
[TBL] [Abstract][Full Text] [Related]
24. Myelin oligodendrocyte glycoprotein antibodies in neuromyelitis optica spectrum disorder.
de Seze J
Curr Opin Neurol; 2019 Feb; 32(1):111-114. PubMed ID: 30562266
[TBL] [Abstract][Full Text] [Related]
25. Neuromyelitis optica spectrum disorder (NMOSD) presenting as acute transverse myelitis with positive aquaporin 4 antibodies.
Thornley K; Canepa C
BMJ Case Rep; 2021 Jan; 14(1):. PubMed ID: 33504530
[TBL] [Abstract][Full Text] [Related]
26. Neuromyelitis optica with hypothalamic involvement: a case report.
Samart K; Phanthumchinda K
J Med Assoc Thai; 2010 Apr; 93(4):505-9. PubMed ID: 20462097
[TBL] [Abstract][Full Text] [Related]
27. [Clinical characteristics and follow-up of pediatric patients with neuromyelitis optica and neuromyelitis optica spectrum disorders].
Yun W; Weihua Z; Xiaotun R; Jiuwei L; Xinying Y; Junlan L; Changhong D; Chunhong C; Haitao R; Liying C; Fang F
Zhonghua Er Ke Za Zhi; 2015 Apr; 53(4):268-73. PubMed ID: 26182501
[TBL] [Abstract][Full Text] [Related]
28. A rare case of aquaporin-4-antibody-positive neuromyelitis optica associated with bladder cancer.
Yi S; Park H
Mult Scler Relat Disord; 2020 Feb; 38():101499. PubMed ID: 31812041
[TBL] [Abstract][Full Text] [Related]
29. Recurrent spinal cord attacks in a patient with a limited form of neuromyelitis optica.
Matsumoto H; Shimizu T; Okabe S; Konoma Y; Takahashi T; Hirakawa-Yamada M; Igeta Y; Hashida H
Intern Med; 2011; 50(5):509-13. PubMed ID: 21372469
[TBL] [Abstract][Full Text] [Related]
30. Aquaporin-4 IgG neuromyelitis optica spectrum disorder onset after Covid-19 vaccination: Systematic review.
Harahsheh E; Callister M; Hasan S; Gritsch D; Valencia-Sanchez C
J Neuroimmunol; 2022 Dec; 373():577994. PubMed ID: 36332464
[TBL] [Abstract][Full Text] [Related]
31. [Neuromyelitis optica spectrum disorders as initial presentation of Sjögren's syndrome: A case report].
Alva Díaz C; Andamayo Villalba L; Mori N; Ventura Chilón JJ; Romero R
Medwave; 2016 Feb; 16(1):e6388. PubMed ID: 26938585
[TBL] [Abstract][Full Text] [Related]
32. [Neuromyelitis optica].
Kvistad SA; Wergeland S; Torkildsen Ø; Myhr KM; Vedeler CA
Tidsskr Nor Laegeforen; 2013 Oct; 133(19):2057-61. PubMed ID: 24129537
[TBL] [Abstract][Full Text] [Related]
33. Neuromyelitis optica spectrum disorder mimicking multiple sclerosis.
van Rooij LC; Wattjes MP; de Jong BA; van Oosten BW
Mult Scler Relat Disord; 2017 Oct; 17():54-56. PubMed ID: 29055475
[TBL] [Abstract][Full Text] [Related]
34. Neuromyelitis optica.
Matiello M; Jacob A; Wingerchuk DM; Weinshenker BG
Curr Opin Neurol; 2007 Jun; 20(3):255-60. PubMed ID: 17495617
[TBL] [Abstract][Full Text] [Related]
35. Serum anti-aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder presenting as acute eosinophilic encephalomyelitis.
Muroishi T; Sakai K; Yanase D; Ikeda Y; Machiya T; Kato-Motozaki Y; Samuraki M; Yamada M
J Clin Neurosci; 2018 Feb; 48():93-94. PubMed ID: 29137920
[TBL] [Abstract][Full Text] [Related]
36. "Hot Cord" Sign on 18F-FDG PET/CT in a Patient With Acute Myelitis Due to Neuromyelitis Optica Spectrum Disorder.
Alkhaja MA; Cheng LTJ; Loi HY; Sinha AK
Clin Nucl Med; 2021 Jan; 46(1):74-75. PubMed ID: 33181735
[TBL] [Abstract][Full Text] [Related]
37. Central nervous system Aquaporin4 autoimmunity revealed by a single pseudotumoral encephalic lesion.
Fargeot G; Aboab J; Savatovsky J; Marignier R; Lecler A; Gout O
Metab Brain Dis; 2018 Feb; 33(1):353-355. PubMed ID: 29090380
[TBL] [Abstract][Full Text] [Related]
38. Vaccines and the association with relapses in patients with neuromyelitis optica spectrum disorder.
Mealy MA; Cook LJ; Pache F; Velez DL; Borisow N; Becker D; Arango JAJ; Paul F; Levy M
Mult Scler Relat Disord; 2018 Jul; 23():78-82. PubMed ID: 29783157
[TBL] [Abstract][Full Text] [Related]
39. Short segment myelitis as a first manifestation of neuromyelitis optica spectrum disorders.
Huh SY; Kim SH; Hyun JW; Jeong IH; Park MS; Lee SH; Kim HJ
Mult Scler; 2017 Mar; 23(3):413-419. PubMed ID: 28067584
[TBL] [Abstract][Full Text] [Related]
40. Severe Relapse After Cessation of Immunosuppressive Therapy in a Patient With Neuromyelitis Optica Spectrum Disorder.
Hyun JW; Kim G; Kim Y; Jeong IH; Kim SH; Kim HJ
Neurologist; 2016 Nov; 21(6):97-98. PubMed ID: 27801768
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
